Ramot, the technology transfer company of Tel Aviv University (TAU) has signed a collaboration with the Bayer pharmaceutical company to test new drugs on 3D-printed heart tissues, a new, more efficient method of testing.
Prior to reaching the pharmaceutical shelves, drugs must undergo a complicated process of trials and screenings which include testing on human tissue cultures in petri dishes, and are often tested on animals before finally being approved for human clinical trials. The new method of testing on 3D-printed hearts bypasses many of these screening methods, making it faster, cheaper and more efficient. “In a petri dish, all the cells line up in 2D, and it’s only one type of cell” […]
Trumpf’s new nozzle technology increases the coating speed to well over 600 square centimetres a minute, even reaching...